Melanoma-Specific Antigens

Name
Melanoma-Specific Antigens
Accession Number
DBCAT004631
Description

Cellular antigens that are specific for MELANOMA cells.

Drugs
DrugDrug Description
Melanoma antigen recognized by T-cells 1Melanoma antigen recognized by T-cells 1 is under investigation in clinical trial NCT01748747 (Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery).
GP-100 antigenGP-100 antigen is under investigation in clinical trial NCT00006385 (Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma).
Drugs & Drug Targets
DrugTargetType